Strong Applied Science Sales Help Push Roche Diagnostics' Q1 Revenues up 7 Percent

The firm's molecular diagnostics sales were flat year over year, but Roche said uptake for its new cobas 4800 MDx system has been "very encouraging." Meanwhile, its microarray sales were up 40 percent.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories